Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03674424
Title Avelumab as Neoadjuvant Therapy in Subjects With Urothelial Muscle Invasive Bladder Cancers (AURA Trial) (AURA)
Acronym AURA
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jules Bordet Institute
Age Groups: adult | senior
Covered Countries FRA | BEL

No variant requirements are available.